Holmen ended 2016 on a convincing note as the Q4 16 (and full-year) results were ahead of AV’s (and consensus) estimates. Despite sluggish top-line, … Q4 sales were up (6.7% yoy; 3.3% qoq) to SEK3.9bn. The performance across divisions was healthy / reasonable, Forests in particular (+3.9% yoy; +16% qoq). Moreover, Energy witnessed a staggering sequential volume (+52%) and price recovery, after a dismal Q3 16. But the full-year sales were down (3.1%) to SEK15.5bn, with varying deg
10 Mar 2017
Clinical Q4 results; relatively better positioned vis-à-vis peers
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Clinical Q4 results; relatively better positioned vis-à-vis peers
Holmen ended 2016 on a convincing note as the Q4 16 (and full-year) results were ahead of AV’s (and consensus) estimates. Despite sluggish top-line, … Q4 sales were up (6.7% yoy; 3.3% qoq) to SEK3.9bn. The performance across divisions was healthy / reasonable, Forests in particular (+3.9% yoy; +16% qoq). Moreover, Energy witnessed a staggering sequential volume (+52%) and price recovery, after a dismal Q3 16. But the full-year sales were down (3.1%) to SEK15.5bn, with varying deg